What one share of Rigel Pharmaceuticals holds
We are a biotechnology company dedicated to developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. We focus on products that address signaling pathways that are critical to disease mechanisms.
Rigel Pharmaceuticals’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $14.15 |
|---|---|
| Profit | $16.46 |
| Cash and investments | $3.26 |
| Debt | $2.14 |
| Book value | $22.77 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | — | −$27.29 | — | — | — | — |
| 2010 | — | $7.21 | $0.68 | $8.21 | — | — |
| 2011 | — | −$13.58 | $0.36 | −$11.32 | — | — |
| 2012 | — | −$13.18 | $0.45 | −$11.82 | — | — |
| 2013 | — | −$10.20 | $0.14 | −$10.00 | — | — |
| 2014 | — | −$10.37 | $0.05 | −$8.00 | — | — |
| 2015 | — | −$5.82 | $0.06 | −$2.71 | — | — |
| 2016 | $2.16 | −$7.33 | $0.09 | −$8.13 | — | — |
| 2017 | $0.35 | −$6.17 | $0.01 | −$6.15 | — | — |
| 2018 | $2.77 | −$4.39 | $0.07 | −$3.73 | — | — |
| 2019 | $3.54 | −$4.00 | $0.09 | −$2.57 | — | — |
| 2020 | $6.44 | −$1.76 | $0.07 | −$3.17 | — | — |
| 2021 | $8.75 | −$1.10 | $0.04 | $0.31 | — | — |
| 2022 | $7.05 | −$3.44 | $0.03 | −$4.35 | — | — |
| 2023 | $6.72 | −$1.44 | — | — | — | — |
| 2024 | $10.14 | $0.99 | — | — | — | — |
| 2025 | $15.62 | $19.48 | — | — | — | $21.38 |
Common questions about Rigel Pharmaceuticals
How much does one share of Rigel Pharmaceuticals earn?
Over the last 12 months, each share of Rigel Pharmaceuticals earned $16.46 of profit on $14.15 of sales, keeping about 116¢ of every $1 (profit margin).
Does Rigel Pharmaceuticals pay a dividend?
Rigel Pharmaceuticals didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Rigel Pharmaceuticals’s book value per share?
Rigel Pharmaceuticals’s book value is $22.77 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Rigel Pharmaceuticals have?
Each share of Rigel Pharmaceuticals has $3.26 of cash and investments and $2.14 of debt, as of June 30, 2026.
Has Rigel Pharmaceuticals bought back shares?
Rigel Pharmaceuticals’s share count rose about 361% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.